BR112015031088A2 - composições e métodos de imunização contra c. difficile - Google Patents
composições e métodos de imunização contra c. difficileInfo
- Publication number
- BR112015031088A2 BR112015031088A2 BR112015031088A BR112015031088A BR112015031088A2 BR 112015031088 A2 BR112015031088 A2 BR 112015031088A2 BR 112015031088 A BR112015031088 A BR 112015031088A BR 112015031088 A BR112015031088 A BR 112015031088A BR 112015031088 A2 BR112015031088 A2 BR 112015031088A2
- Authority
- BR
- Brazil
- Prior art keywords
- difficile
- toxin
- patient
- methods against
- immunization compositions
- Prior art date
Links
- 241000193163 Clostridioides difficile Species 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 101710182532 Toxin a Proteins 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361835246P | 2013-06-14 | 2013-06-14 | |
| PCT/US2014/042298 WO2014201346A1 (en) | 2013-06-14 | 2014-06-13 | Compositions and methods of immunizing against c. difficile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015031088A2 true BR112015031088A2 (pt) | 2017-07-25 |
Family
ID=51168412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015031088A BR112015031088A2 (pt) | 2013-06-14 | 2014-06-13 | composições e métodos de imunização contra c. difficile |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9730994B2 (enExample) |
| EP (1) | EP3007724B1 (enExample) |
| JP (1) | JP6691477B2 (enExample) |
| KR (1) | KR20160020543A (enExample) |
| CN (1) | CN105611942A (enExample) |
| AU (1) | AU2014277981B2 (enExample) |
| BR (1) | BR112015031088A2 (enExample) |
| CA (1) | CA2915279A1 (enExample) |
| MX (1) | MX2015017257A (enExample) |
| SG (1) | SG11201510166YA (enExample) |
| TW (1) | TWI648063B (enExample) |
| WO (1) | WO2014201346A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012245904B2 (en) | 2011-04-22 | 2016-04-21 | Wyeth Llc | Compositions relating to a mutant Clostridium difficile toxin and methods thereof |
| BR122016023101B1 (pt) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| SG11201510166YA (en) | 2013-06-14 | 2016-01-28 | Sanofi Pasteur Inc | Compositions and methods of immunizing against c. difficile |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| IL320444A (en) * | 2017-09-28 | 2025-06-01 | Pfizer | Compositions and methods for stimulating an immune response against Clostridium difficile |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5071759A (en) | 1986-05-30 | 1991-12-10 | The United States Of America As Represented By The Secretary Of The Army | Hybridoma cell lines and monoclonal antibodies to clostridum difficile toxins A and B |
| US6214341B1 (en) | 1997-10-20 | 2001-04-10 | Oravax | Passive immunization against Clostridium difficile disease |
| US6969520B2 (en) | 1997-10-20 | 2005-11-29 | Acambis Inc. | Active immunization against clostridium difficile disease |
| CN101855336B (zh) * | 2007-09-14 | 2019-07-30 | 赛诺菲巴斯德生物制剂有限责任公司 | 含艰难梭菌类毒素a和b的药物组合物 |
| GB0921288D0 (en) | 2009-12-04 | 2010-01-20 | Health Prot Agency | Therapies for preventing or suppressing clostridium difficile infection |
| AU2012245904B2 (en) | 2011-04-22 | 2016-04-21 | Wyeth Llc | Compositions relating to a mutant Clostridium difficile toxin and methods thereof |
| AR089797A1 (es) | 2012-01-27 | 2014-09-17 | Merck Sharp & Dohme | Vacunas contra clostridum difficile que comprenden toxinas recombinantes |
| GB201206070D0 (en) | 2012-04-04 | 2012-05-16 | Health Prot Agency | Clostridium difficile antigens |
| JP2016516721A (ja) | 2013-03-15 | 2016-06-09 | サノフィ パストゥール インコーポレイテッド | トキソイド、組成物および関連方法 |
| BR112015023469A8 (pt) * | 2013-03-15 | 2019-12-03 | Sanofi Pasteur Inc | toxóides, composições e métodos relacionados |
| SG11201510166YA (en) | 2013-06-14 | 2016-01-28 | Sanofi Pasteur Inc | Compositions and methods of immunizing against c. difficile |
-
2014
- 2014-06-13 SG SG11201510166YA patent/SG11201510166YA/en unknown
- 2014-06-13 MX MX2015017257A patent/MX2015017257A/es unknown
- 2014-06-13 CN CN201480044768.7A patent/CN105611942A/zh active Pending
- 2014-06-13 WO PCT/US2014/042298 patent/WO2014201346A1/en not_active Ceased
- 2014-06-13 AU AU2014277981A patent/AU2014277981B2/en not_active Ceased
- 2014-06-13 KR KR1020167001130A patent/KR20160020543A/ko not_active Ceased
- 2014-06-13 JP JP2016519675A patent/JP6691477B2/ja active Active
- 2014-06-13 CA CA2915279A patent/CA2915279A1/en not_active Abandoned
- 2014-06-13 US US14/897,870 patent/US9730994B2/en active Active
- 2014-06-13 EP EP14737429.2A patent/EP3007724B1/en active Active
- 2014-06-13 BR BR112015031088A patent/BR112015031088A2/pt not_active Application Discontinuation
- 2014-06-16 TW TW103120772A patent/TWI648063B/zh not_active IP Right Cessation
-
2017
- 2017-07-10 US US15/645,057 patent/US20170304423A1/en not_active Abandoned
-
2019
- 2019-10-21 US US16/658,278 patent/US20200113991A1/en not_active Abandoned
-
2021
- 2021-01-08 US US17/144,486 patent/US11419930B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI648063B (zh) | 2019-01-21 |
| MX2015017257A (es) | 2016-11-11 |
| SG11201510166YA (en) | 2016-01-28 |
| CA2915279A1 (en) | 2014-12-18 |
| JP6691477B2 (ja) | 2020-04-28 |
| US9730994B2 (en) | 2017-08-15 |
| EP3007724A1 (en) | 2016-04-20 |
| EP3007724B1 (en) | 2023-07-05 |
| US20200113991A1 (en) | 2020-04-16 |
| AU2014277981B2 (en) | 2019-06-20 |
| US20170304423A1 (en) | 2017-10-26 |
| US20160120968A1 (en) | 2016-05-05 |
| CN105611942A (zh) | 2016-05-25 |
| US20210145956A1 (en) | 2021-05-20 |
| US11419930B2 (en) | 2022-08-23 |
| JP2016521754A (ja) | 2016-07-25 |
| WO2014201346A1 (en) | 2014-12-18 |
| TW201536314A (zh) | 2015-10-01 |
| KR20160020543A (ko) | 2016-02-23 |
| AU2014277981A1 (en) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015031088A2 (pt) | composições e métodos de imunização contra c. difficile | |
| NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
| BR112017013891A2 (pt) | composições imunogênicas para uso em vacinas pneumocócicas | |
| BR112017001796A2 (pt) | composições de flagelina e seus usos | |
| MX2019008564A (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas. | |
| BR112017012344A2 (pt) | anticorpos anti-c10orf54 e usos dos mesmos | |
| AR097178A1 (es) | Diagnóstico y terapias anticáncer que comprenden células madre cancerosas | |
| ECSP18001613A (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| BR112013018920A2 (pt) | composições de nanopartículas, formulações destas e seus usos | |
| BR112016013562A2 (pt) | Anticorpos anti-tau(ps422) humanizados, seus usos, e formulações farmacêuticas | |
| EA201691443A1 (ru) | Накожное восстановление иммунобаланса | |
| MX2015012833A (es) | Composiciones antibioticas de ceftolozano. | |
| MX2022011167A (es) | Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. | |
| BR112017014343A2 (pt) | composição contendo quitina e proteínas digeríveis | |
| BR112013018642A2 (pt) | vacinas e composições contra streptococcus pneumoniae | |
| BR112016028227A2 (pt) | método para redução de imunogenicidade de proteína e peptídeo | |
| BR112017000519A2 (pt) | "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica" | |
| CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
| EA201790958A1 (ru) | Сублингвальный препарат рилузола | |
| MX2016008397A (es) | Composicion para usarse en el tratamiento de tos persistente. | |
| BR112018068342A2 (pt) | vacina de vírus zika vivo atenuado | |
| BR112017015159A2 (pt) | preparação e uso de produtos plaquetários | |
| BR112018069682A2 (pt) | métodos de tratamento para doenças colestáticas e fibróticas | |
| PH12016500766A1 (en) | Age-tailored nutritional compositions with a varying protein content | |
| BR112016027383A8 (pt) | derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |